STIPLEX Trademark

Trademark Overview


On Thursday, December 21, 2023, a trademark application was filed for STIPLEX with the United States Patent and Trademark Office. The USPTO has given the STIPLEX trademark a serial number of 98326981. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, October 31, 2024. This trademark is owned by SpeeDx Pty Ltd. The STIPLEX trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules being diagnostic reagents and preparations, except for medical or veterinary use for the purpose of detection and identification of pathogens, for the detection of antibiotic resistance, and medical diagnostic reagents for the analysis of body fluids specifically for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, and for analysis of response to therapy and preparations for detecting and preparations for analysis of gene expression specifically for medical or medical research purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing preparations being nucleic acid sequences for medical use; chemical preparations containing enzymes for medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistanc...

Reagents for scientific or medical research use; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acid for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase for scientific purposes; chemicals used in environmental monitoring in the nature of chemical preparations for scientific purposes, other than for medical or veterinary use;

Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health care services specifically dna, genetics and genetic testing for medical purposes; medical diagnostic services in the nature of medical testing and medical analysis services for diagnostic purposes provided by medical laboratories; medical diagnostic imaging and molecular medicine being medical services; molecular medical diagnostics testing;

Surgical apparatus and instruments; medical instrument for diagnostic use, namely, apparatus for medical diagnostic testing to diagnose and identify pathogens, infections, and infectious diseases, or other tissue-based diagnostic testing, cytology and cell-based testing specifically for the purposes of analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical diagnostic apparatus for diagnosis and identification of, infections, and infectious diseases; diagnostic testing kits consisting primarily of medical apparatus and instruments for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; point of care medical devices, namely, a device for testing fo...

Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; product development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services to diagnose and identify pathogens, infections, and infectious diseases for medical or scientific research purposes; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services ...
stiplex

General Information


Serial Number98326981
Word MarkSTIPLEX
Filing DateThursday, December 21, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized word STIPlex.
Goods and ServicesPharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules being diagnostic reagents and preparations, except for medical or veterinary use for the purpose of detection and identification of pathogens, for the detection of antibiotic resistance, and medical diagnostic reagents for the analysis of body fluids specifically for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, and for analysis of response to therapy and preparations for detecting and preparations for analysis of gene expression specifically for medical or medical research purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing preparations being nucleic acid sequences for medical use; chemical preparations containing enzymes for medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical kits containing medical diagnostic reagents for testing and analysis of bodily fluids for use in disease detection and/or analysis of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping; diagnostic preparations for medical or veterinary use; biological chemical diagnostic test kits in the nature of medical diagnostic reagents and assays for testing body fluids for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders;
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesReagents for scientific or medical research use; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acid for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase for scientific purposes; chemicals used in environmental monitoring in the nature of chemical preparations for scientific purposes, other than for medical or veterinary use;
Goods and ServicesMedical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health care services specifically dna, genetics and genetic testing for medical purposes; medical diagnostic services in the nature of medical testing and medical analysis services for diagnostic purposes provided by medical laboratories; medical diagnostic imaging and molecular medicine being medical services; molecular medical diagnostics testing;
Goods and ServicesSurgical apparatus and instruments; medical instrument for diagnostic use, namely, apparatus for medical diagnostic testing to diagnose and identify pathogens, infections, and infectious diseases, or other tissue-based diagnostic testing, cytology and cell-based testing specifically for the purposes of analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical diagnostic apparatus for diagnosis and identification of, infections, and infectious diseases; diagnostic testing kits consisting primarily of medical apparatus and instruments for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; point of care medical devices, namely, a device for testing for diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; biological chemical test kits containing diagnostic preparations for medical purposes used in medical laboratories in the nature of nucleic acid substrates used for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders;
Goods and ServicesScientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; product development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services to diagnose and identify pathogens, infections, and infectious diseases for medical or scientific research purposes; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services for scientific purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom in the nature of genetic testing for scientific research purposes; scientific research namely provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; custom design and development of biochemical assays;

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, December 21, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, December 21, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 21, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 21, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSpeeDx Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEveleigh, NSW 2015
AU

Trademark Events


Event DateEvent Description
Thursday, December 21, 2023NEW APPLICATION ENTERED
Monday, April 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 22, 2024ASSIGNED TO EXAMINER
Tuesday, July 30, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 30, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED